These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16223891)

  • 1. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.
    Langton KP; McKie N; Smith BM; Brown NJ; Barker MD
    Hum Mol Genet; 2005 Dec; 14(23):3579-86. PubMed ID: 16223891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
    Chong NH; Alexander RA; Gin T; Bird AC; Luthert PJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):898-902. PubMed ID: 10711711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.
    Qi JH; Ebrahem Q; Yeow K; Edwards DR; Fox PL; Anand-Apte B
    J Biol Chem; 2002 Apr; 277(16):13394-400. PubMed ID: 11821400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells.
    Majid MA; Smith VA; Easty DL; Baker AH; Newby AC
    FEBS Lett; 2002 Oct; 529(2-3):281-5. PubMed ID: 12372614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.
    Fariss RN; Apte SS; Luthert PJ; Bird AC; Milam AH
    Br J Ophthalmol; 1998 Nov; 82(11):1329-34. PubMed ID: 9924344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A.
    Jacobson SG; Cideciyan AV; Regunath G; Rodriguez FJ; Vandenburgh K; Sheffield VC; Stone EM
    Nat Genet; 1995 Sep; 11(1):27-32. PubMed ID: 7550309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
    Li Z; Clarke MP; Barker MD; McKie N
    Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
    Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
    Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium.
    Della NG; Campochiaro PA; Zack DJ
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1921-4. PubMed ID: 8759363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells.
    Majid MA; Smith VA; Easty DL; Baker AH; Newby AC
    Br J Ophthalmol; 2002 Jan; 86(1):97-101. PubMed ID: 11801512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.
    Knupp C; Chong NH; Munro PM; Luthert PJ; Squire JM
    J Struct Biol; 2002; 137(1-2):31-40. PubMed ID: 12064931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.
    Majid MA; Smith VA; Newby AC; Dick AD
    Br J Ophthalmol; 2007 Aug; 91(8):1073-6. PubMed ID: 17383996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.
    Weber BH; Vogt G; Pruett RC; Stöhr H; Felbor U
    Nat Genet; 1994 Dec; 8(4):352-6. PubMed ID: 7894485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy.
    Langton KP; McKie N; Curtis A; Goodship JA; Bond PM; Barker MD; Clarke M
    J Biol Chem; 2000 Sep; 275(35):27027-31. PubMed ID: 10854443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model for Sorsby fundus dystrophy.
    Weber BH; Lin B; White K; Kohler K; Soboleva G; Herterich S; Seeliger MW; Jaissle GB; Grimm C; Reme C; Wenzel A; Asan E; Schrewe H
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2732-40. PubMed ID: 12147610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-3 mRNA is not overexpressed in Sorsby fundus dystrophy.
    Chong NH; Kvanta A; Seregard S; Bird AC; Luthert PJ; Steen B
    Am J Ophthalmol; 2003 Nov; 136(5):954-5. PubMed ID: 14597066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
    Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
    Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.
    Soboleva G; Geis B; Schrewe H; Weber BH
    J Cell Physiol; 2003 Oct; 197(1):149-56. PubMed ID: 12942551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene].
    Copete-Piqueras S; Cava-Valenciano C; Flores-Moreno I; Moreno-Valladares A; Bautista Ruescas V
    Arch Soc Esp Oftalmol; 2013 Jun; 88(6):240-3. PubMed ID: 23726310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.
    Lin RJ; Blumenkranz MS; Binkley J; Wu K; Vollrath D
    Am J Ophthalmol; 2006 Nov; 142(5):839-48. PubMed ID: 16989765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.